Non invasive mechanical ventilation in cystic fibrosis: physiological effects and monitoring.

Monaldi Arch Chest Dis

Paediatric Pulmonary Department, INSERM E 213, Armand Trousseau Hospital, Paris, France.

Published: July 2003

Chronic respiratory insufficiency in cystic fibrosis (CF) is characterised by an increase in respiratory load, which leads to alveolar hypoventilation with the preservation of respiratory muscle strength. Non-invasive mechanical ventilation (NIMV) is able to improve alveolar ventilation and thus gas exchange and allow the the respiratory muscles to rest in patients with cystic fibrosis with variable severity of lung disease. These effects state the superiority of NIMV compared to oxygen therapy in CF. Invasive, highly specialized monitoring is recommended for the evaluation of ventilatory modes and the performances of new ventilators. After a successful evaluation, the monitoring of patients starting NIMV can be performed with simple, non invasive parameters such as gas exchange, tidal volume, respiratory rate, minute ventilation and comfort. In the long term however, studies are warranted to assess the benefit of NIMV in terms of lung function, quality of sleep and most importantly, quality of life.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cystic fibrosis
12
mechanical ventilation
8
gas exchange
8
respiratory
5
invasive mechanical
4
ventilation
4
ventilation cystic
4
fibrosis physiological
4
physiological effects
4
effects monitoring
4

Similar Publications

Restoring natural killer cell activity in lung injury with 1,25-hydroxy vitamin D: a promising therapeutic approach.

Front Immunol

January 2025

Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

Background And Aim: NK cells and NK-cell-derived cytokines were shown to regulate neutrophil activation in acute lung injury (ALI). However, the extent to which ALI regulates lung tissue-resident NK (trNK) activity and their molecular phenotypic alterations are not well defined. We aimed to assess the impact of 1,25-hydroxy-vitamin-D3 [1,125(OH)D] on ALI clinical outcome in a mouse model and effects on lung trNK cell activations.

View Article and Find Full Text PDF

Unlabelled: Diminishing marginal lifespan utility (DMLU) implies that a particular lifespan increment (e.g., 1 life-year) confers lesser marginal utility if added to longer lifespans (e.

View Article and Find Full Text PDF

Background: Clinical severity and progression of lung disease in cystic fibrosis (CF) are significantly influenced by the degree of lung inflammation. Non-invasive quantitative diagnostic tools are desirable to differentiate structural and inflammatory lung changes in order to help prevent chronic airway disease. This might also be helpful for the evaluation of longitudinal effects of novel therapeutics.

View Article and Find Full Text PDF

Introduction: Following two weeks of application of the triple combination therapy of Elexacaftor (E), Tezacaftor (T), and Ivacaftor (I) known as ETI, substantial pulmonary improvement in patients with cystic fibrosis is well-documented. However, few detailed data are available on the action of this treatment over the course of these first 14 days.

Methods: In this prospective study (NCT05599230), 20 patients aged≥12 years, all of them eligible for ETI, were recruited at the initiation of treatment.

View Article and Find Full Text PDF

Lung transplantation and bone health: A narrative review.

J Heart Lung Transplant

January 2025

Department of Medicine, University Health Network and Sinai Health System, University of Toronto, Toronto, ON, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada; Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada. Electronic address:

Bone health after lung transplantation has not been comprehensively reviewed in over two decades. This narrative review summarizes available literature on bone health in the context of lung transplantation, including epidemiology, presentation and post-operative management. Osteoporosis is reported in approximately 30-50% of lung transplant candidates, largely due to disease-related impact on bone and lifestyle, and corticosteroid-related effects during end-stage lung disease (interstitial lung diseases, chronic obstructive pulmonary disease, and historically cystic fibrosis).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!